Four notes on Zimmer Biomet’s first quarter financial results:
1. Zimmer Biomet’s net sales from continuing operations saw a 3.9 percent increase from the first quarter of 2021, the company said May 3.
2. The company saw $73 million in net earnings from continuing operations.
3. Diluted earnings per share from continuing operations for the company were $0.35.
4. Zimmer Biomet also completed the spinoff of ZimVie, its spine and dental business, in March.
